12:00 AM
 | 
Aug 15, 2011
 |  BC Week In Review  |  Company News  |  Other News

Gilead, Astellas infectious news

Gilead said FDA accepted the company's response to a warning letter issued last year over violations of cGMP regulations identified during an inspection of the company's San Dimas, Calif., manufacturing facility. Gilead said the issues were primarily related...

Read the full 169 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >